vs
Side-by-side financial comparison of BLACKBERRY Ltd (BB) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $141.8M, roughly 1.1× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs 7.8%, a 1.9% gap on every dollar of revenue. On growth, BLACKBERRY Ltd posted the faster year-over-year revenue change (-0.8% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $17.4M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 17.8%).
BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
BB vs NUTX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $141.8M | $151.7M |
| Net Profit | $13.7M | $11.8M |
| Gross Margin | 77.5% | 30.4% |
| Operating Margin | 8.4% | 20.4% |
| Net Margin | 9.7% | 7.8% |
| Revenue YoY | -0.8% | -41.1% |
| Net Profit YoY | 224.5% | -80.8% |
| EPS (diluted) | $0.02 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $141.8M | $151.7M | ||
| Q3 25 | $129.6M | $267.8M | ||
| Q2 25 | $121.7M | $244.0M | ||
| Q1 25 | $141.7M | $211.8M | ||
| Q4 24 | $143.6M | $257.6M | ||
| Q3 24 | $126.2M | $78.8M | ||
| Q2 24 | $123.4M | $76.1M | ||
| Q1 24 | $102.1M | $67.5M |
| Q4 25 | $13.7M | $11.8M | ||
| Q3 25 | $13.3M | $55.4M | ||
| Q2 25 | $1.9M | $-17.7M | ||
| Q1 25 | $-7.4M | $21.2M | ||
| Q4 24 | $-10.5M | $61.6M | ||
| Q3 24 | $-19.7M | $-8.8M | ||
| Q2 24 | $-41.4M | $-364.0K | ||
| Q1 24 | $-56.2M | $-364.0K |
| Q4 25 | 77.5% | 30.4% | ||
| Q3 25 | 74.5% | 57.8% | ||
| Q2 25 | 74.2% | 51.2% | ||
| Q1 25 | 73.5% | 55.9% | ||
| Q4 24 | 78.1% | 55.0% | ||
| Q3 24 | 70.2% | 27.8% | ||
| Q2 24 | 72.9% | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | 8.4% | 20.4% | ||
| Q3 25 | 8.9% | 48.7% | ||
| Q2 25 | 1.6% | 13.8% | ||
| Q1 25 | -5.6% | 38.1% | ||
| Q4 24 | 13.6% | 44.4% | ||
| Q3 24 | 1.7% | 12.3% | ||
| Q2 24 | -10.5% | 7.0% | ||
| Q1 24 | 50.0% | 2.1% |
| Q4 25 | 9.7% | 7.8% | ||
| Q3 25 | 10.3% | 20.7% | ||
| Q2 25 | 1.6% | -7.3% | ||
| Q1 25 | -5.2% | 10.0% | ||
| Q4 24 | -7.3% | 23.9% | ||
| Q3 24 | -15.6% | -11.2% | ||
| Q2 24 | -33.5% | -0.5% | ||
| Q1 24 | -55.0% | -0.5% |
| Q4 25 | $0.02 | $2.34 | ||
| Q3 25 | $0.02 | $7.76 | ||
| Q2 25 | $0.00 | $-2.95 | ||
| Q1 25 | $-0.01 | $3.33 | ||
| Q4 24 | $-0.02 | $11.56 | ||
| Q3 24 | $-0.03 | $-1.72 | ||
| Q2 24 | $-0.07 | $-0.07 | ||
| Q1 24 | $-0.08 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $304.2M | $185.6M |
| Total DebtLower is stronger | $196.2M | — |
| Stockholders' EquityBook value | $741.1M | $329.4M |
| Total Assets | $1.2B | $918.5M |
| Debt / EquityLower = less leverage | 0.26× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $304.2M | $185.6M | ||
| Q3 25 | $290.5M | $166.0M | ||
| Q2 25 | $306.6M | $96.7M | ||
| Q1 25 | $337.8M | $84.7M | ||
| Q4 24 | $220.0M | $40.6M | ||
| Q3 24 | $211.0M | $46.9M | ||
| Q2 24 | $229.0M | $40.8M | ||
| Q1 24 | $237.1M | $30.0M |
| Q4 25 | $196.2M | — | ||
| Q3 25 | $195.9M | — | ||
| Q2 25 | $195.6M | — | ||
| Q1 25 | $195.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $194.1M | — |
| Q4 25 | $741.1M | $329.4M | ||
| Q3 25 | $725.1M | $317.2M | ||
| Q2 25 | $725.1M | $235.3M | ||
| Q1 25 | $719.9M | $176.9M | ||
| Q4 24 | $725.2M | $132.4M | ||
| Q3 24 | $732.1M | $60.4M | ||
| Q2 24 | $742.6M | $62.7M | ||
| Q1 24 | $775.1M | $63.0M |
| Q4 25 | $1.2B | $918.5M | ||
| Q3 25 | $1.2B | $964.5M | ||
| Q2 25 | $1.2B | $841.0M | ||
| Q1 25 | $1.3B | $761.9M | ||
| Q4 24 | $1.3B | $655.3M | ||
| Q3 24 | $1.3B | $438.5M | ||
| Q2 24 | $1.3B | $422.4M | ||
| Q1 24 | $1.4B | $404.3M |
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.3M | $70.4M |
| Free Cash FlowOCF − Capex | $17.4M | $69.0M |
| FCF MarginFCF / Revenue | 12.3% | 45.5% |
| Capex IntensityCapex / Revenue | 0.6% | 0.9% |
| Cash ConversionOCF / Net Profit | 1.34× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $42.8M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.3M | $70.4M | ||
| Q3 25 | $3.9M | $99.5M | ||
| Q2 25 | $-18.0M | $27.3M | ||
| Q1 25 | $41.6M | $51.0M | ||
| Q4 24 | $6.0M | $54.0K | ||
| Q3 24 | $-16.0M | $6.8M | ||
| Q2 24 | $-15.1M | $13.3M | ||
| Q1 24 | $-15.5M | $3.1M |
| Q4 25 | $17.4M | $69.0M | ||
| Q3 25 | $3.1M | $99.2M | ||
| Q2 25 | $-18.9M | $26.5M | ||
| Q1 25 | $41.2M | $50.9M | ||
| Q4 24 | $5.2M | $-341.0K | ||
| Q3 24 | $-16.5M | $6.2M | ||
| Q2 24 | $-16.5M | $12.7M | ||
| Q1 24 | $-17.6M | $2.3M |
| Q4 25 | 12.3% | 45.5% | ||
| Q3 25 | 2.4% | 37.0% | ||
| Q2 25 | -15.5% | 10.9% | ||
| Q1 25 | 29.1% | 24.0% | ||
| Q4 24 | 3.6% | -0.1% | ||
| Q3 24 | -13.1% | 7.8% | ||
| Q2 24 | -13.4% | 16.7% | ||
| Q1 24 | -17.2% | 3.4% |
| Q4 25 | 0.6% | 0.9% | ||
| Q3 25 | 0.6% | 0.1% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 0.6% | 0.2% | ||
| Q3 24 | 0.4% | 0.8% | ||
| Q2 24 | 1.1% | 0.7% | ||
| Q1 24 | 2.1% | 1.1% |
| Q4 25 | 1.34× | 5.95× | ||
| Q3 25 | 0.29× | 1.80× | ||
| Q2 25 | -9.47× | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BB
| QNX | $68.7M | 48% |
| Secure Communication | $67.0M | 47% |
| Licensing | $6.1M | 4% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
